WO2024246607 - COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION
National phase entry is expected:
Publication Number
WO/2024/246607
Publication Date
05.12.2024
International Application No.
PCT/IB2024/000291
International Filing Date
30.05.2024
Title **
[English]
COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION
[French]
COMPOSITIONS POUR PÉNÉTRATION MUCOSALE AMÉLIORÉE
Applicants **
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
Inventors
HARUTA, Shunji
Priority Data
63/505,344
31.05.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
JPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5235 | |
| EPO | Filing, Examination, Granting | 116205 | |
| Japan | Filing, Examination, Granting | 4641 | |
| South Korea | Filing, Examination, Granting | 8686 | |
| USA | Filing, Examination, Granting | 25340 |
Total:
160,107
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein are compositions and methods related to a solid dosage form comprising an absorption enhancer. The composition enhances the mucosal penetration and absorption of active ingredients.[French]
L'invention concerne des compositions et des méthodes associées à une forme posologique solide comprenant un activateur d'absorption. La composition améliore la pénétration mucosale et l'absorption de principes actifs.